Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic Variations of VEGFA Gene Are Associated With Infiltration of Adjacent Tissues and the Clinical Outcome of Patients With Nasopharyngeal Carcinoma.
Psoma E, Koliou GA, Dimitrakopoulos FI, Papadopoulou K, Rontogianni D, Bobos M, Visvikis A, Kosmidis PA, Fountzilas G, Constantinidis J, Kalogera-Fountzila A. Psoma E, et al. Among authors: visvikis a. Anticancer Res. 2020 Feb;40(2):677-688. doi: 10.21873/anticanres.13997. Anticancer Res. 2020. PMID: 32014908
An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.
Pectasides D, Kalofonos HP, Samantas E, Nicolaides C, Papacostas P, Onyenadum A, Visvikis A, Skarlos D, Fountzilas G. Pectasides D, et al. Among authors: visvikis a. Anticancer Res. 2001 Jul-Aug;21(4B):3005-10. Anticancer Res. 2001. PMID: 11712802 Clinical Trial.
Genetic Variation in the Vascular Endothelial Growth Factor (VEGFA) Gene at rs13207351 Is Associated with Overall Survival of Patients with Head and Neck Cancer.
Dimitrakopoulos FI, Koliou GA, Kotoula V, Papadopoulou K, Markou K, Vlachtsis K, Angouridakis N, Karasmanis I, Nikolaou A, Psyrri A, Visvikis A, Kosmidis P, Fountzilas G, Koutras A. Dimitrakopoulos FI, et al. Among authors: visvikis a. Cancers (Basel). 2021 Mar 8;13(5):1163. doi: 10.3390/cancers13051163. Cancers (Basel). 2021. PMID: 33800431 Free PMC article.
Tumor Genotyping and Homologous Recombination Repair Gene Variants in Patients With Epithelial Ovarian Cancer: Is Pathogenic Enough?
Fountzilas E, Kotoula V, Koliou GA, Liontos M, Papadopoulou K, Giannoulatou E, Papanikolaou A, Tikas I, Chrisafi S, Mauri D, Chatzopoulos K, Fostira F, Pectasides D, Oikonomopoulos G, Aivazi D, Andrikopoulou A, Visvikis A, Aravantinos G, Zagouri F, Fountzilas G. Fountzilas E, et al. Among authors: visvikis a. Front Oncol. 2021 Jun 1;11:683057. doi: 10.3389/fonc.2021.683057. eCollection 2021. Front Oncol. 2021. PMID: 34141624 Free PMC article.
Investigation of prognostic biomarkers in patients with urothelial carcinoma treated with platinum-based regimens.
Papadopoulou K, Koliou GA, Tsimiliotis D, Kotoula V, Foukas P, Goussia A, Tsiatas M, Visvikis A, Chatzopoulos K, Nifora M, Charchanti A, Koumarianou A, Christodoulou C, Pectasides D, Psyrri A, Fostira F, Fountzilas G, Samantas E. Papadopoulou K, et al. Among authors: visvikis a. Urol Oncol. 2022 Dec;40(12):538.e15-538.e24. doi: 10.1016/j.urolonc.2022.07.007. Epub 2022 Aug 28. Urol Oncol. 2022. PMID: 36041976
Investigation of Clinically Significant Molecular Aberrations in Patients with Prostate Cancer: Implications for Personalized Treatment, Prognosis and Genetic Testing.
Fountzilas E, Kouspou M, Eliades A, Papadopoulou K, Bournakis E, Goussia A, Tsiatas M, Achilleos A, Tsangaras K, Billioud G, Loizides C, Lemesios C, Kypri E, Ioannides M, Koumbaris G, Levva S, Vakalopoulos I, Paliouras A, Pervana S, Koinis F, Bumci R, Christopoulou A, Meditskou S, Psyrri A, Boukovinas I, Visvikis A, Karavasilis V, Koukoulis GK, Kotsakis A, Giannakis D, Fountzilas G, Patsalis PC. Fountzilas E, et al. Among authors: visvikis a. Int J Mol Sci. 2023 Jul 23;24(14):11834. doi: 10.3390/ijms241411834. Int J Mol Sci. 2023. PMID: 37511593 Free PMC article.
Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03).
Bamias A, Dafni U, Karadimou A, Timotheadou E, Aravantinos G, Psyrri A, Xanthakis I, Tsiatas M, Koutoulidis V, Constantinidis C, Hatzimouratidis C, Samantas E, Visvikis A, Chrisophos M, Stravodimos K, Deliveliotis C, Eleftheraki A, Pectasides D, Fountzilas G, Dimopoulos MA. Bamias A, et al. Among authors: visvikis a. Ann Oncol. 2013 Apr;24(4):1011-7. doi: 10.1093/annonc/mds583. Epub 2012 Nov 7. Ann Oncol. 2013. PMID: 23136231 Free article. Clinical Trial.
68 results